Article Correctness Is Author's Responsibility: Alzheimer’s Drug Discovery Foundation announces the first award recipients of its Diagnostics Accelerator Program

(Alzheimer's Drug Discovery Foundation) The Alzheimer's Drug Discovery Foundation (ADDF) announced today the first group of researchers who will receive funding through its Diagnostics Accelerator, a new research program that aims to fast-track the development of diagnostic tools and biomarkers for Alzheimer's disease and related dementias.